RxDoctor Payments Data

Jennifer Robinson

Cardiovascular Disease · Iowa City, IANPI 1780672212

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,761 of the $36,542 with a category attached, or 92.4%. 5 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 45.6% of the total. Among cardiovascular disease clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,542in general payments, 2019–2025

Across 23 payments — averaging $1588.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$17K
  • Regeneron$12K
  • Pfizer$8K
  • Eli Lilly$91
  • Novartis$25
$1,242,244in research payments, 2019–2025

Across 234 payments — averaging $5308.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$554K
  • Novo Nordisk AS$292K
  • Eli Lilly$200K
  • Regeneron$54K
  • AstraZeneca$53K
  • Novartis$26K
  • plus $64K from 5 others

What the payments were for

  • Consulting fees$33,76192%
  • Travel & lodging$2,3366%
  • Food & beverage$4241%
  • Education$210%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi-aventis U.S. LLC7$16,670
Regeneron11$11,853
Pfizer3$7,903
Eli Lilly1$91
Novartis1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,542 in reported general payments places this provider in the 95th percentile of 142 cardiovascular disease providers in Iowa.

See all cardiovascular disease providers in Iowa

Other cardiovascular disease in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →